Lotus Eye Hospital & Institute (BOM:532998) Piotroski F-Score: 5 (As of Jul. 05, 2026) — 29% Below Median


BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
71 GF Score
Price ₹129.65
GF Value ₹91.90
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Lotus Eye Hospital & Institute Piotroski F-Score?

Lotus Eye Hospital & Institute BOM:532998 +2.49% 71 Piotroski F-Score is 5 as of Jul. 05, 2026, which is 29% below its 10-year median of 7.00. GuruFocus rates BOM:532998 with a GF Score™ of 71/100 and a GF Value™ of ₹91.90 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 649 Healthcare Providers & Services companies, Lotus Eye Hospital & Institute ranks better than 54.55% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lotus Eye Hospital & Institute has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Lotus Eye Hospital & Institute's Piotroski F-Score or its related term are showing as below:

BOM:532998' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 7   Max: 9
Current: 5

During the past 13 years, the highest Piotroski F-Score of Lotus Eye Hospital & Institute was 9. The lowest was 5. And the median was 7.

Lotus Eye Hospital & Institute  (BOM:532998) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Lotus Eye Hospital & Institute Piotroski F-Score Related Terms


Lotus Eye Hospital & Institute Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute Piotroski F-Score Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 9.00 5.00 5.00 5.00

Lotus Eye Hospital & Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 0.00 0.00 5.00

BOM:532998 vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Eye Hospital & Institute Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Lotus Eye Hospital & Institute's Piotroski F-Score falls into.


BOM:532998
71GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹0.8 Mil.
Cash Flow from Operations was ₹30.2 Mil.
Revenue was ₹537.1 Mil.
Gross Profit was ₹261.5 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (695.737 + 825.974) / 2 = ₹760.8555 Mil.
Total Assets at the begining of this year (Mar25) was ₹695.7 Mil.
Long-Term Debt & Capital Lease Obligation was ₹130.1 Mil.
Total Current Assets was ₹113.7 Mil.
Total Current Liabilities was ₹93.4 Mil.
Net Income was ₹7.4 Mil.

Revenue was ₹495.6 Mil.
Gross Profit was ₹246.6 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (666.267 + 695.737) / 2 = ₹681.002 Mil.
Total Assets at the begining of last year (Mar24) was ₹666.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₹20.3 Mil.
Total Current Assets was ₹115.7 Mil.
Total Current Liabilities was ₹74.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lotus Eye Hospital & Institute's current Net Income (TTM) was 0.8. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lotus Eye Hospital & Institute's current Cash Flow from Operations (TTM) was 30.2. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=0.804/695.737
=0.00115561

ROA (Last Year)=Net Income/Total Assets (Mar24)
=7.393/666.267
=0.01109615

Lotus Eye Hospital & Institute's return on assets of this year was 0.00115561. Lotus Eye Hospital & Institute's return on assets of last year was 0.01109615. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Lotus Eye Hospital & Institute's current Net Income (TTM) was 0.8. Lotus Eye Hospital & Institute's current Cash Flow from Operations (TTM) was 30.2. ==> 30.2 > 0.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=130.096/760.8555
=0.17098648

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=20.267/681.002
=0.02976056

Lotus Eye Hospital & Institute's gearing of this year was 0.17098648. Lotus Eye Hospital & Institute's gearing of last year was 0.02976056. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=113.741/93.433
=1.21735361

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=115.701/74.246
=1.55834658

Lotus Eye Hospital & Institute's current ratio of this year was 1.21735361. Lotus Eye Hospital & Institute's current ratio of last year was 1.55834658. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Lotus Eye Hospital & Institute's number of shares in issue this year was 20.1. Lotus Eye Hospital & Institute's number of shares in issue last year was 20.536. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=261.472/537.141
=0.48678466

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=246.594/495.625
=0.49754149

Lotus Eye Hospital & Institute's gross margin of this year was 0.48678466. Lotus Eye Hospital & Institute's gross margin of last year was 0.49754149. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=537.141/695.737
=0.77204605

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=495.625/666.267
=0.74388346

Lotus Eye Hospital & Institute's asset turnover of this year was 0.77204605. Lotus Eye Hospital & Institute's asset turnover of last year was 0.74388346. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+1+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lotus Eye Hospital & Institute has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Lotus Eye Hospital & Institute (BOM:532998) has a Piotroski F-Score of 5 as of Jul. 05, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Lotus Eye Hospital & Institute and its competitors. This is 29% below median its historical median of 7.00. Over the past decade, Lotus Eye Hospital & Institute's Piotroski F-Score has ranged from 5.00 to 9.00. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #295 out of 649 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is Lotus Eye Hospital & Institute's Piotroski F-Score too high?
Lotus Eye Hospital & Institute's current Piotroski F-Score of 5 is 29% below median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 9.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Lotus Eye Hospital & Institute's value of 5 is 0% at this industry median. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #295 out of 649 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #295 out of 649 companies for Piotroski F-Score. This puts Lotus Eye Hospital & Institute in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Lotus Eye Hospital & Institute's value of 5 is 0% at this benchmark. Historically, Lotus Eye Hospital & Institute's own Piotroski F-Score has ranged from 5.00 to 9.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, Lotus Eye Hospital & Institute has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 649 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lotus Eye Hospital & Institute's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current Piotroski F-Score is 5, which is 29% below median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹91.90, compared to a current price of ₹129.65 — trading 41.1% above its estimated fair value. The current Piotroski F-Score is 5, which is 29% below median its 10-year median of 7.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Lotus Eye Hospital & Institute's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Piotroski F-Score is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹129.65 is trading 41.1% above its estimated GF Value™ of ₹91.90. GuruFocus considers Lotus Eye Hospital & Institute to be Significantly Overvalued.

Key valuation signals for BOM:532998:

  • Piotroski F-Score: 5 (29% below median its 10-year median of 7.00)
  • GF Value™: ₹91.90 vs. price of ₹129.65 (41.1% above fair value)
  • GF Score™: 71/100 with 4 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#295 of 649)

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
71GF Score

Get the complete analysis for BOM:532998

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹129.65
Price
₹91.90
GF Value